Assessing the biocompatibility and stability of CeO
Journal
RSC medicinal chemistry
ISSN: 2632-8682
Titre abrégé: RSC Med Chem
Pays: England
ID NLM: 101759460
Informations de publication
Date de publication:
27 Sep 2024
27 Sep 2024
Historique:
received:
08
07
2024
accepted:
31
08
2024
medline:
30
9
2024
pubmed:
30
9
2024
entrez:
30
9
2024
Statut:
aheadofprint
Résumé
The application of nanoparticles is promising for the purposes of nuclear medicine due to the possibilities of using them as vectors and transporters of radionuclides. In this study, we have successfully synthesised conjugates of CeO
Identifiants
pubmed: 39345713
doi: 10.1039/d4md00515e
pii: d4md00515e
pmc: PMC11428044
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
The authors of this work declare that they have no conflicts of interest.